Overall Survival Extended by Adding Bevacizumab or Cetuximab to Standard Chemo Regimens in Patients With Metastatic Colorectal Cancer & No KRAS Mutations
Year: 2014
Type: article
Author: Michael Kaufman
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2939662662